Skip to main content

and
  1. No Access

    Article

    Hormonal Treatment in Recurrent and Metastatic Gynaecological Cancers: A Review of the Current Literature

    For many years hormonal treatment has played a role in the treatment of a selected group of patients with a variety of recurrent or metastatic gynaecological cancers, including ovarian and endometrial carcinom...

    Dirkje W. Sommeijer, Katrin M. Sjoquist, Michael Friedlander in Current Oncology Reports (2013)

  2. Article

    Open Access

    Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy

    Initial dose of chemotherapy is planned based on body surface area, which does not take body composition into account. We studied the association between fat mass (kg and relative to total body weight) as well...

    Maaike M. G. A. van den Berg, Dieuwertje E. Kok in Breast Cancer Research and Treatment (2019)

  3. Article

    Open Access

    Perceptions of involvement in advance care planning and emotional functioning in patients with advanced cancer

    Advance Care Planning (ACP) is positively associated with the quality of care, but its impact on emotional functioning is ambiguous. This study investigated the association between perceptions of ACP involveme...

    Lente L. Kroon, Janneke van Roij, Ida J. Korfage in Journal of Cancer Survivorship (2021)

  4. Article

    Open Access

    Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone

    Patient selection for addition of anti-EGFR therapy to chemotherapy for patients with RAS and BRAF wildtype metastatic colorectal cancer can still be optimised. Here we investigate the effect of anti-EGFR therapy...

    Sanne ten Hoorn, Dirkje W. Sommeijer, Faye Elliott in British Journal of Cancer (2021)